Spector Roseman Kodroff & Willis

Amsterdam Court of Appeal renders landmark opinion in SRKW’s Converium/SCOR action that will benefit American, European and other investors
SRKW partners Robert Roseman and Mark Willis led the successful efforts to make it easier for American and European investors to use Dutch courts when they are barred from joining U.S. shareholder actions because of jurisdictional constraints instituted by the U.S. Supreme Court in Morrison v. National Australia Banks (more . . .)

SRKW A Leader In Case Challenging Effexor Pricing
SRKW has been appointed to lead litigation challenging Wyeth’s and Teva’s efforts to artificially inflate the price of the anti-depressant drug Effexor XR by conspiring to keep generic versions off the market. Based on SRKW’s experience in handling complex class actions, as well as the work it had already performed, Judge Joel Pisano of the U.S. District Court in Trenton, New Jersey appointed SRKW to the Executive Committee of firms leading a nationwide group of end-payor plaintiffs who overpaid for Effexor XR. SRKW has a significant history of successfully prosecuting cases against drug manufacturers that illegally inflate drug prices. The firm’s efforts have recovered over $1 billion for consumers and health plans. SRKW’s efforts are led by Jeffrey Kodroff and John Macoretta.

SRKW's Blood Reagents antitrust case upheld against defendants' efforts to dismiss it. (more . . .)

SRKW Appointed Co-Lead Counsel in In re Life Partners Holdings, Inc. Derivative Litigation
On July 19, 2011, the District Court for the Western District of Texas appointed SRKW to serve as Co-Lead Counsel in the shareholder derivative litigation involving Life Partners Holdings, Inc. The lawsuit alleges members of the company’s board breached their fiduciary duties to Life Partners by engaging in various unlawful business practices, which has caused the SEC to issue a Wells Notice, an indication of a regulatory investigation and a precursor to civil charges.

SRKW Appointed Co-Lead Counsel in In re Synthes, Inc. Shareholder Litigation
On May 27, 2011, the Delaware Court of Chancery appointed SRKW to serve as Co-Lead Counsel in the Synthes shareholder litigation. The class action involves the proposed sale of Synthes to Johnson & Johnson in a transaction valued at approximately $21.3 billion and alleges Synthes’ board breached its fiduciary duties to shareholders by agreeing to a merger that undervalues the company and provides inadequate consideration, and because Synthes’ proxy failed to disclose material information relating to the merger.

SRKW files suit over defective Chevy Impalas
SRKW filed a lawsuit alleging that General Motors breached its warranties on 2007 and 2008 Chevrolet Impalas due to a defective spindle rod (a part in the rear suspension) which causes the tires to be misaligned and wear very prematurely. (more . . .)

SRKW involved in providing over $4 million to charities
SRKW is lead counsel in two cases where significant amounts have recently been awarded to charity. It sometimes happens that a portion of a settlement fund remains after all class members with valid claims are paid. When this happens Courts can, and often do, award such funds to charities under the doctrine of cy pres, on the idea that the funds will be used for a purpose "as close as possible' to the goals of the lawsuit. In two cases where SRKW serves as co-lead counsel amounts of $73,000 and $4 million were recently given to charities suggested by SRKW and approved by the Court. (more . . .)

SRKW partner selected for Fulbright Specialists Program
Partner Ted Lieverman has been selected to participate in the Fulbright Specialists Program sponsored by the U.S. Department of State. He spent three weeks in April lecturing on electoral reform and U.S. constitutional law at the Faculty of Law, University of Belgrade, Serbia. Earlier this year, Lieverman also served as an adjunct professor at the Faculty of Law, Vytautas Magnus University, Kaunas, Lithuania.

SRKW forces enhanced disclosures to shareholders regarding the Qualcomm/Atheros deal
SRKW obtained a preliminary injunction postponing the shareholder vote on the Qualcomm/Atheros deal (more . . .)

In a landmark ruling, the Dutch Court of Appeal recently ruled it has jurisdiction to oversee the Converium/Scor trans-Atlantic class action settlement negotiated by SRKW.
(more . . .)

SRKW sponsored a CLE program at the Pyramid Club titled "Sports & Antitrust: Know the Score."
On November 10, 2010, SRKW sponsored a CLE program at the Pyramid Club titled "Sports & Antitrust: Know the Score." The program featured SRKW partners Eugene A. Spector and Jeffrey J. Corrigan, as well as Comcast SportsNet Anchor Michael Barkann. (more . . .)

SRKW named sole Interim Lead Counsel in Blood Reagents action
SRKW has been named sole Interim Lead Class Counsel, and Jeffrey Corrigan as Liaison Counsel, in In re Blood Reagents Antitrust Litigation, MDL 09-2081 (E.D. Pa.), a nation-wide, price-fixing class action into the market for blood reagents, which are used for testing blood.

Partner Mark Willis speaks to European investors about the growth of non-US actions
In June 2010, SRKW partner Mark Willis participated in a Brussels-based webcast organized by Deminor, Europe's leading investor rights and corporate governance company. Mr. Willis focused on the development of investor rights in Europe and around the world and how these impact US and European investors.(more . . .)

Court Allows Wire Tap Claim to Proceed Against Google
In a case of first impression that the court said "presents a novel question of statutory interpretation," U.S. District Judge James Ware upheld plaintiffs' claim that Google's Street View mapping system intentionally collected data transmitted over unencrypted Wi-Fi networks in violation of the federal Wiretap Act. Judge Ware allowed the class lawsuit against Google to proceed.(more . . .)

SRKW appointed to co-lead Babies 'R' Us action
SRKW was appointed to co-lead the price fixing class action against Babies 'R' Us and others which involves allegations of coercing manufacturers into adopting vertical price restraints to prevent retail discounting and insulate Babies 'R' Us from price competition. (more . . .)

SRKW Announces Roll-Back of Drug Prices and Final Approval of $350 Million McKesson Settlement (more . . .)

SRKW Announces Important Appellate Victories in AWP Litigation
SRKW was part of the lead Counsel team that has just secured two important rulings from the First Circuit Court of Appeals in the massive Average Wholesale Price ("AWP") litigation (more . . .)

SRKW complimented by judge in the Parmalat case
In the Parmalat litigation the court noted that SRKW and its co-counsel "did a wonderful job here for the class and were in all respects totally professional and totally prepared. I wish I had counsel this good in front of me in every case."

Judge compliments SRKW in approving landmark settlement
In approving the landmark $120 million settlement of the In Re OSB Antitrust Litigation, Judge Diamond of the federal court in Philadelphia stated: "Counsel have represented their clients with consummate skill and efficiency, bringing this massive matter to conclusion in less than three years. Lead class counsel – Jeffrey Corrigan and the other lawyers from Spector Roseman Kodroff & Willis – performed brilliantly in this exceptionally difficult case."
(more . . .)

SRKW is actively investigating claims against banks and mortgage lenders for unfair treatment of homeowners both before and during the foreclosure process
SRKW is investigating claims against Wells Fargo relating to its mortgage default and foreclosure practices, as well as several other banks.
(more . . .)

SRKW receives Chancellor's Award
SRKW receives Chancellor's Award for pro bono work on behalf of homeowners facing foreclosure
(more . . .)

SRKW negotiates $145 million first-of-its-kind trans-Atlantic securities settlement
SRKW negotiated a $145 million recovery on behalf of a global class of investors in the Converium/Scor action. In an unprecedented move, the case was settled on two continents, in New York and Amsterdam — the first such trans-Atlantic resolution to a securities class action.
(more . . .)

U.S. Parmalat class action reaches $90 million in settlements
SRKW has been among three firms leading the Parmalat action (Europe’s Enron), where we have obtained settlements thus far valued at $90 million, as well as innovative governance reforms.
(more . . .)

SRKW nominated as Class Action Law Firm of the Year
SRKW was nominated in 2007 and 2008 for the prestigious Class Action Law Firm of the Year award by Global Pensions magazine. Nominees are selected by pension funds around the world.

Northern Ireland Local Governmental Officers' Superannuation Committee appointed co-lead plaintiff in Lehman Brothers securities class action
SRKW's client, the Northern Ireland Local Governmental Officers' Superannuation Committee (NILGOSC), was recently appointed as a co-lead plaintiff in the Lehman Brothers Holdings securities class action pending in the Southern District of New York. Partner Robert Roseman noted that NILGOSC's role "shows that European institutional investors, in the appropriate case, are taking an active role in US class actions when they have no other legal recourse in their own country."
(more . . .)

SRKW client part of historic pan-European Royal Dutch Shell settlement
SRKW represented a large European investor in the pan-European settlement of the Royal Dutch Shell action in the Netherlands, where European investors will share in the distribution of $450 million.
(more . . .)

SRKW files derivative action in California court on behalf of Genentech, Inc.
SRKW is seeking to maximize shareholder value by instituting a shareholder derivative suit on behalf of Genentech. This suit alleges that when Roche Holding AG, which owns approximately 56% of Genentech, sought to acquire the remaining shares, it did so at an unfair price — in breach of the fiduciary duties it and Genentech’s directors owed to the company’s shareholders.

Court upholds SRKW's consumer protection class action against GM, Volkswagen, Honda and Subaru relating to the failure of analog OnStar equipment (more . . .)

SRKW Obtains $120 Million in Settlements from OSB Manufacturers
SRKW has negotiated $120 million in settlements of a major antirust case against nine manufacturers of Oriented Strand Board (OSB), a wood-based building material used in most residential construction. SRKW developed and prosecuted this case against the major manufacturers of OSB, who conspired to fix, raise, maintain and stabilize the prices at which OSB was sold in the U.S. This prosecution has now resulted in $120 million in settlements. (more . . .)

SRKW represents ERISA plan participants to bring important changes to the plan (more . . .)

SRKW's efforts lead to class members being compensated at 140% of their damages (more . . .)